Literature DB >> 22712167

Inhaled corticosteroids in persons with HIV infection: not that harmless.

S Spruyt1, E Vlieghe, P Bomans, F Moerman, R Colebunders, J Van den Ende.   

Abstract

There is a growing group of HIV-seropositive patients at risk for chronic lung disease due to their life style and age. The interaction between certain antiretroviral drugs and corticosteroid inhalation therapy is potentially dangerous but often unrecognised. We present three cases from our HIV-clinic of whom two developed full blown Cushing's syndrome over a short period of time and one presented with asymptomatic hypocortisolaemia due to serious drug interactions between HIV-drugs and inhaled corticosteroids. General practitioners, HIV and chest physicians should all be aware of this potentially life-threatening interaction and the combination of those products should be avoided where possible.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22712167     DOI: 10.2143/ACB.67.2.2062641

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN: 1784-3286            Impact factor:   1.264


  2 in total

1.  Iatrogenic Cushing Syndrome from Interaction Between Ritonavir and Oral Budesonide During Direct Acting Antiviral Hepatitis C Therapy.

Authors:  Sern Wei Yeoh
Journal:  J Clin Exp Hepatol       Date:  2016-05-20

Review 2.  Inhaled corticosteroid use in HIV-positive individuals taking protease inhibitors: a review of pharmacokinetics, case reports and clinical management.

Authors:  P Saberi; T Phengrasamy; D P Nguyen
Journal:  HIV Med       Date:  2013-04-16       Impact factor: 3.180

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.